EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

NCT04437368 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
98
Enrollment
INDUSTRY
Sponsor class

Stopped Terminated for interim analysis demonstrating futility (trial highly unlikely to meet efficacy outcome). The trial is not ending early because of medical problems or concerns.

Conditions

Interventions

Sponsor

Gyroscope Therapeutics Limited

Collaborators